EKErin Kelty

Erin Kelty

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erin Kelty has a total of 352 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Patterns of Care in Patients With Cervical Cancer in Western Australia: A Retrospective Cohort Study

    by Kate Mannolini, Elizabeth Nathan, Yee Leung, Raphael Chee, Erin Kelty, Kayleigh Gieliam, Fieke Teertstra, Cathy van de Graaf, Emma R. Allanson, Chloe Ayres, et al.

    Background: Cervical cancer is an important public health concern with underserved populations having higher incidence and mortality. Aims: To examine associations between patient and tumour characteristics, receipt of appropriate treatment and survival. Materials and Methods: Retrospective cohort study of cervical cancer patients managed by the Western Australian Gynaecological Cancer Service from 1 January 2009 to 31 December 2018. Appropriate treatment was defined by international guidelines. Univariable and multivariable analyses assessed associations between demographic and tumour factors and receipt of appropriate treatment. Survival outcomes were evaluated using multivariable Cox regression. Results: Of 526 patients included, 95.4% received treatment, of which 94.4% received appropriate treatment. Non‐English‐speaking patients had reduced odds of completing treatment (OR 0.28, 95% CI 0.10–0.80, p = 0.018), and patients of lower socioeconomic status had reduced odds of timely treatment (OR 0.57, 95% CI 0.35–0.93, p = 0.025). Patients aged over 60 years had lower odds of receiving any, complete and timely treatment. Those diagnosed between 2014 and 2018, versus 2009–2013 had increased odds of completing treatment (OR 3.08, 95% CI 1.45–6.45, p = 0.003). Higher disease stage was associated with lower odds of receiving and completing treatment. Overall‐ and disease‐free survival were poorer among patients aged over 60, those with advanced‐stage disease, those diagnosed in 2009–2013, and those who received incomplete treatment or no treatment. Conclusions: Most patients received appropriate treatment. Non‐English‐speaking patients, older patients, and those of low socioeconomic status were less likely to receive appropriate care. Older age, advanced disease stage, diagnosis in 2009–2013, and incomplete treatment were associated with poorer survival.

  • Open Access

    The impact of heatwaves on maternal, neonatal and child health outcomes in Western Australian climate zones: A protocol paper for a retrospective cohort study

    by Erin Kelty, Aster Gebremedhin, Kerrie Mengersen, Shane K Maloney, Peter Le Souef, Michael Kearney, Alexander Larcombe, Amina Rhaman, Melinda Judge, Aiden Price, et al.

    Background Rising global temperatures have resulted in an increase in the frequency and severity of heatwaves. Pregnancy is a time of substantial physiological change and thus maternal and neonatal health outcomes are susceptible to adverse effects of heat. There is a lack of knowledge about thermoregulation in pregnancy, including how effectively pregnant people adapt in different climate contexts and what specific environmental conditions present the largest thermoregulatory challenges. The primary aim of this study is to examine the associations between exposure to heatwaves during pregnancy and maternal, neonatal, and child health outcomes in Western Australia climatic regions. Methods All neonates born in Western Australia between 1991 and 2023 will be identified from perinatal records (~960,000 neonates). Perinatal records will be linked to weather data from the ERA5 database using Statistical Area 2 geocoding to identify heatwave exposed pregnancies. Commonly used definitions of heatwave exposure will be tested against three neonatal outcomes (pre-term birth, low birth weight, and congenital anomalies). From this, a single or small number of definition will be selected to examine maternal, neonatal, and child health outcomes using linked hospital, emergency department, and education assessment data, as well as data from the Western Australian congenital anomalies and death register. The association between heatwaves during pregnancy and health outcomes will be performed using generalised estimating equations, adjusting for covariates including, but not limited to, cigarette smoking, parity, maternal age, socio-economic status, and Aboriginality where appropriate. Stratification by socio-economic status and geographic region will also be carried out. Discussion Examining the association between exposure to heatwaves in pregnancy and maternal, neonatal and child outcomes is important given the increasing frequency of heatwaves. The study will highlight which heat definitions confers the highest vulnerability as well as demographic and geographic subgroups who are particularly vulnerable to the effects of heatwaves. It will provide valuable information for future public health planning, including targets for intervention.

  • Open Access

    The impact of heatwaves on maternal, neonatal and child health outcomes in Western Australian climate zones: A protocol paper for a retrospective cohort study

    by Erin Kelty, Aster Gebremedhin, Kerrie Mengersen, Shane K Maloney, Peter Le Souef, Michael Kearney, Alexander Larcombe, Amina Rhaman, Melinda Judge, Aiden Price, et al.

    Background Rising global temperatures have resulted in an increase in the frequency and severity of heatwaves. Pregnancy is a time of substantial physiological change and thus maternal and neonatal health outcomes are susceptible to adverse effects of heat. There is a lack of knowledge about thermoregulation in pregnancy, including how effectively pregnant people adapt in different climate contexts and what specific environmental conditions present the largest thermoregulatory challenges. The primary aim of this study is to examine the associations between exposure to heatwaves during pregnancy and maternal, neonatal, and child health outcomes in Western Australia climatic regions. Methods All neonates born in Western Australia between 1991 and 2023 will be identified from perinatal records (~960,000 neonates). Perinatal records will be linked to weather data from the ERA5 database using Statistical Area 2 geocoding to identify heatwave exposed pregnancies. Commonly used definitions of heatwave exposure will be tested against three neonatal outcomes (pre-term birth, low birth weight, and congenital anomalies). From this, a single definition will be selected to examine maternal, neonatal, and child health outcomes using linked hospital, emergency department, and education assessment data, as well as data from the Western Australian congenital anomalies and death register. The association between heatwaves during pregnancy and health outcomes will be performed using generalised estimating equations, adjusting for covariates including, but not limited to, cigarette smoking, parity, maternal age, socio-economic status, and Aboriginality where appropriate. Stratification by socio-economic status and geographic region will also be carried out. Discussion Examining the association between exposure to heatwaves in pregnancy and maternal, neonatal and child outcomes is important given the increasing frequency of heatwaves. The study will highlight which heat definitions confers the highest vulnerability as well as demographic and geographic subgroups who are particularly vulnerable to the effects of heatwaves. It will provide valuable information for future public health planning, including targets for intervention.

  • Open Access

    Under Control? Mouse Models of Heat Exposure: A Systematic Review of Experimental Design and Methodology

    by Amina H. Rhaman, Leaf R. Kardol, Shane K. Maloney, Ebony Quintrell, Elizabeth Sorial, Shannon Morgan, Danielle J. Russell, Erin Kelty, Caitlin S. Wyrwoll

    Mouse models are widely used to study heat‐related physiological responses as they provide insights relevant to human health. However, species differences (including nocturnal behavior) and standard housing below the thermoneutral zone (TNZ; 26°C–34°C) can confound comparisons. This systematic review evaluates methodologies, including housing temperatures, used in mouse heat‐exposure studies published over the past 4 years. Medline, Web of Science, and Embase were searched for peer‐reviewed mouse heat‐exposure studies published from 2020 to 10 January 2025. Data on housing temperature, heat‐exposure protocols, and physiological outcomes were extracted. Screening and extraction were conducted independently and in duplicate in Covidence. One hundred seventy studies were included. Of those, 142 (83%) housed control mice below TNZ; seven (4%) studies maintained TNZ conditions and the remainder did not report control temperature. Heat exposures ranged from 30°C–45°C, most commonly 39°C–41°C. Body temperature was measured in 110 (65%) studies, often targeting ~42°C. When timing was reported, exposures occurred mainly during the light phase (52, 30%). Most studies used males only (116, 68%); 31 (18%) used females only; 9 (5%) included both sexes; and 14 (8%) did not report sex. Common outcomes were digestive (55, 32%), inflammatory (47, 28%), and central nervous system (40, 24%). Recent mouse heat‐exposure studies often compare heat‐exposed animals with cold‐stressed controls and apply daytime exposures that conflict with the nocturnal behavior of mice and human diurnal pattern. Incomplete reporting of housing conditions limits interpretation. Future research should account for differences between mice and humans to improve translational relevance. Trial Registration: PROSPERO : CRD42024611316

  • Open Access

    Deprescribing in Older People: A Clinical Practice Guideline Summary

    by Hui Wen Quek, Xisco Reus Perello, Kenneth Lee, Atinuke Abraham, Leon A. Adams, Osvaldo P. Almeida, Hend Almutairi, Bree Armstrong, Leanne Boase, Juanita Breen, et al.

    Introduction: Older people face higher risks of medicine‐related harm due to polypharmacy and the use of potentially inappropriate medicines. Current treatment guidelines rarely specify when to stop medicines, leading to medicines often being continued indefinitely without a clear deprescribing plan. While deprescribing guidelines exist for some medicine classes, limited guidance is a major barrier to deprescribing. These new guidelines address this gap by providing structured recommendations that complement more detailed drug‐specific deprescribing guidance, disease‐specific therapeutic guidelines and non‐pharmacological management resources. These guidelines were developed by a team of 72 experts, including consumer representatives, and were further shaped by feedback from public consultation and independent reviewers. Main Recommendations: The guidelines are intended for all healthcare professionals involved in prescribing, dispensing or administering medicines to older people. The guidelines specifically address polypharmacy and medicines commonly dispensed for regular use in people aged ≥ 65 years, as well as other medicines where there is evidence to consider deprescribing in this cohort. The guidelines provide 185 consensus‐based recommendations and 70 good practice statements, covering both specific medicine categories and general deprescribing principles. The guidelines are structured into four areas: (1) when to deprescribe; (2) ongoing treatment needs; (3) how to deprescribe; and (4) monitoring requirements. Changes in Care as a Result of the Guideline: This guideline emphasises deprescribing as an integral part of the prescribing continuum. Applying a deprescribing approach encourages prescribers to consider the ongoing need for a medicine each time a prescription is re‐issued, to balance benefits and harms as they evolve over time, and to ensure treatment decisions reflect an individual's goals through shared decision‐making. The guideline was developed based on currently available evidence for deprescribing and expert multidisciplinary and consumer input. It supports health professionals in reviewing regular medicines, minimising harm and planning ongoing treatment or monitoring. The detailed guideline is available at https://deprescribing.com .


  • Open Access

    The impact of heatwaves on maternal, neonatal and child health outcomes in Western Australian climate zones: A protocol paper for a retrospective cohort study

    by Erin Kelty, Aster Gebremedhin, Kerrie Mengersen, Shane K Maloney, Peter Le Souef, Michael Kearney, Alexander Larcombe, Amina Rhaman, Melinda Judge, Aiden Price, et al.

    Background Rising global temperatures have resulted in an increase in the frequency and severity of heatwaves. Pregnancy is a time of substantial physiological change and thus maternal and neonatal health outcomes are susceptible to adverse effects of heat. There is a lack of knowledge about thermoregulation in pregnancy, including how effectively pregnant people adapt in different climate contexts and what specific environmental conditions present the largest thermoregulatory challenges. The primary aim of this study is to examine the associations between exposure to heatwaves during pregnancy and maternal, neonatal, and child health outcomes in Western Australia (WA) climatic regions. Methods All neonates born in WA between 1991 and 2023 will be identified from perinatal records (~960,000 neonates). Perinatal records will be linked to weather data from the ERA5 database using Statistical Area 2 geocoding to identify heatwave exposed pregnancies. Commonly used definitions of heatwave exposure will be tested against three neonatal outcomes (pre-term birth, low birth weight, and congenital anomalies). From this, a single definition will be selected to examine maternal, neonatal, and child health outcomes using linked hospital, emergency department, and education assessment data, as well as data from the WA congenital anomalies and death register. The association between heatwaves during pregnancy and health outcomes will be performed using generalised estimating equations, adjusting for covariates including cigarette smoking, parity, maternal age, and Aboriginality where appropriate. Stratification by socio-economic status and geographic region will also be carried out. Discussion Examining the association between exposure to heatwaves in pregnancy and maternal, neonatal and child outcomes is important given the increasing frequency of heatwaves. The study will highlight which heat definitions confers the highest vulnerability as well as demographic and geographic subgroups who are particularly vulnerable to the effects of heatwaves. It will provide valuable information for future planning, including targets for intervention.

  • Association Between First‐Trimester Medication Exposure in Pregnancy and Congenital Anomalies: A Scoping Review of Cohorts, Exposure, Trimester and Congenital Anomaly Definitions

    by Stephanie Tan, Ebony Quintrell, Shannon Morgan, Amina Rhaman, Danielle Russell, Leaf Kardol, Caitlin Wyrwoll, Bianca Varney, Annelies Robijn, Jonathan Brett, et al.

    Background: The risk of congenital anomalies following first‐trimester medication exposure is an important indicator of medication safety during pregnancy. Retrospective cohort studies using routinely collected data are commonly used to assess this risk, yet methodological inconsistencies—such as how cohorts, exposures, timings and outcomes are defined—can compromise reproducibility and validity. This scoping review examined the methodologies used in retrospective cohort studies assessing the association between first‐trimester prenatal medication exposure and congenital anomalies. Methods: Medline, PsycInfo, Embase, CINAHL and Global Health were searched for retrospective cohort studies published in English between 2014 and 2024 examining the association between first‐trimester medication exposure and congenital anomalies. Screening and data extraction were performed by two reviewers, using Covidence. Results: A total of 156 studies were included. Most were conducted in Europe (56%) using database or registry studies (87%). Common exclusions included stillbirths (58%), multiple pregnancies (41%) and exposure to teratogenic medications (39%). Exposure was typically defined as a minimum of one prescription dispensed during the first trimester (79%); however, the definition of pregnancy start varied across studies: 29% used the date of the last menstrual period, while 42% used the estimated day of conception. The end of the first trimester was defined as Week 12 (16%), Week 13 (30%) or Week 14 (15%). The types of included anomalies differed, with chromosomal anomalies (48%), minor anomalies (14.5%) and genetic anomalies (13.5%) commonly excluded. Comparison groups included untreated individuals without the condition (65%), untreated individuals with the condition (22%) or those receiving alternative treatments (23%). Conclusion: Substantial methodological variation exists in studies examining first‐trimester medication exposure and congenital anomalies. This variation may arise both from inherent differences in data sources and from discretionary methodological decisions made by investigators. Standardised definitions would be beneficial to improve consistency, reliability and interpretability of research in this field.

  • No causal link between the supply of GLP ‐1 receptor agonists and antidepressants: Real‐world evidence from the Australian Pharmaceutical Benefits Scheme

    by Osvaldo P. Almeida, Amy Page, Erin Kelty, Danielle J. Russell, Max Bulsara, Frank M. Sanfilippo, David Preen, Christopher Etherton‐Beer

  • Open Access

    Prenatal nitrate and nitrite intake in mammals: A scoping review of effects and associations with pregnancy and maternal and child health

    by Leaf R. Kardol, Amina Rhaman, Erin Kelty, Shannon Morgan, Danielle J. Russell, Aster Gebremedhin, Sarah Bourke, Caitlin S. Wyrwoll


  • Open Access

    The prevalence of persistent opioid use following dispensed dental opioid prescriptions in Australia

    by Leanne Teoh, Marietta Taylor, Mathew Lim, Michael McCullough, Amy Page, Frank M Sanfilippo, Christopher Etherton-Beer, David Preen, Erin Kelty